 use l-dopa carbidopa metastat malign melanoma combin l-dopa carbidopa patient metastat melanoma maximum oral dose gram respons patient evalu respons toxic consider patient stop treatment unaccept gastrointestin toxic postur hypotens contrari previou anecdot report evid l-dopa/carbidopa treatment acceler progress metastat melanoma l-dopa/carbidopa ineffect therapi advanc melanoma maximum dose